SlideShare a Scribd company logo
대한생물정신의학회 2018 춘계 학술대회
Construction and Interpretation of
Disease Network using Clinical Data
차의과학대학교 의학전문대학원 정보의학교실
한현욱 (M.D, Ph.D)
stepano7@gmail.com
C.V
 Position
 Head Professor, Dept. of Biomedical Informatics, CHA University
 Head, Healthcare Big Data Laboratory, CHA University (CHABI)
 Scientific Program Committee Member, Translational Bioinformatics Conference
 Instructor, GDA and CPBMI, KOSMI
 Advisor Medibloc, Syntecabio, and MISOinfo
 Education
 CPBMI, Certified Physician in BioMedical Informatics, KOSMI
 Ph.D, Biomedical Informatics, Graduate School of Medicine, CHA University
 M.D, Gradate School of Medicine, CHA University
 M.S, Dept. of Electrical & Computer Engineering, Seoul National University
 B.S, Dept. of Electrical & Computer Engineering, Hanyang University
 Work
 Research Assistant Professor, Dept. of Biomedical Informatics, Ajou University
 Clinical Assistant Professor, Dept. of Preventive Medicine, CHA University
 Research Scientist, Systems Biomedical Informatics Research Center, SNU
 R&D Engineer, LG Electronics R&D Campus
Book
베스트
셀러
Network Science
초연결
초지능
Network Science
나 오바마
삼라
만성
Network in biology
Pathway Network
Biological Network
Protein Interaction
Network
Network biology
Network Medicine
Regulatory
Network
Metabolic
Network
Cell Signaling
Network
Perturbation
Sensitivity Network
Social Network
Disease Network
Drug Target
Network
Network Science
 20C Network (Complex System) Science
 Opposing to Reductionism
 Barabasi et al.
 Network Topologies
Random Network Scale-free Network
Characterization of Real Network
P(k) ∝ λ-γ (2 < γ < 3)
Hub node vs. peripheral node
Evolution
Small world phenomenon
Six degrees of separation
The 80/20 rule
Rich get richer
Achilles' Heel
 Scale-free network
 Network growth
 Preferential attachment
Social Network
Internet Network
Biological Network
log-log
Previous Researches of Biological Network
PPI is scale-free
(Barabasi, 2000)
Centrality & Lethality
rule (Jeong, 2001)
Hubs evolve slowly
(Fraser, 2002)
Disease : clustering,
tissue specificity &
Periphery (Goh, 2007)
Drug target : similar
with disease genes
(Yildirim, 2007)
Disease Network
Data source for Construction of Disease Network
Disease A – Gene 1
Disease B – Gene 1
 Disease A – Gene 1 -- Disease B
 Disease A- Disease B
Previous Disease Network
 Human Genes – Disease network (Koh et al. 2007,
PNAS) : Gene Base
Previous Disease Network
 Human Symptoms – Disease Network (Barabasi et al. 2014,
Nature Communication) : EMR Base
Disease A – Symptom 1
Disease B – Symptom 1
 Disease A – Symptom 1 -- Disease B
 Disease A- Disease B
Previous Disease Network
 Disease Comorbidity Network (Yang Chen, 2015, AMIA)
상병명 : Disease A ,Disease B
 Disease A- Disease B
Motivation
 Definition of Disease (Wiki)
 질병(疾病)이란 유기체의 신체적 기능이 비정상적으로 된 상태를
일컫는다.
 인간에게 있어서 질병이란 넓은 의미에서는 극도의 고통을
비롯해 스트레스, 사회적인 문제, 신체기관의 기능
장애와 죽음에까지를 포괄한다.
 질병이란 개인만에 한정되는 것이 아니어서 사회적으로 큰
맥락에서 이해되기도 한다.
 더 넓게는 사고나 장애, 증후군, 감염, 행동 장애 등을 모두 나타낼
수 있다.
 질병의 종류에는 약 30000가지 정도가 있다고 한다.
Motivation
 Genetic Disease Vs. Non-Genetic Disease
 Many diseases have no genetic basis at all. Usually a physical
injury such as a bone fracture is not caused by genetics when it
is caused by something else. (Of course, there could still be an
underlying genetic cause of weak bones or osteoporosis that
really caused the fracture.) Similarly, a virus or bacterial
infection is caused by an external microbe
 예방의학교과서
 유전체로 설명될 수 있는 질환은 20~30% 정도로 알려져 있음
Most diseases are non-genetic
Motivation
The Same Symptom – Different Disease
DDx is very important!!
Motivation
 Sex
Sex is one of the clinical factors of disease
Motivation
 Age
Age is a important clinical factor of disease
Motivation
History
- Disease
- Drug
- Family
- Socio-economy
- Operation
- Mensturation (F)
A disease is risk factor of another disease
Motivation
 Causality and Risk
Clinically, Disease Network is Directed and Weighted
D1
D2
D4
D5
D3
D1
D2
D4
D5
D3
60
10
20
12
7
32
Non-directed and non- weighted Directed and Weighted
Motivation
 Network Visualization
A clinician likes incidence-based node Presentation
D1
D2
D4
D5
D3
D1
D2
D4
D5
D3
60
10
20
12
7
32
Centrality-based Node Presentation Incidence-based Node Presentation
Motivation
 Navigation of Disease Network
Help for a Clinician and a Cheat Sheet for Research
Problem of Clinical Data
Data
Fragmentation
Claim Data
NHIS Cohort Data
A B C
A B, BC, AC
Sex, Age, Direction, Weight, Duration
Method
• Assumption
• we extracted all combinations of disease-disease pairs
from each patient’s transition based on the assumption
that “previous incidence would become a cause (or act as a
risk factor) of later incidence” .
• Step 1. 3 types of event sequence:
• Incidence sequence
• Ex: A  B  C  D
• Step 2. Extracting disease-disease pairs:
• Disease-disease pairs : (A  B), (A  C), (A  D), (B  C),
(B  D), (C  D)
• Step 3. Record the frequency of each disease-
disease pair
Method
Statistical analysis and constructions of the human disease directed network. A: databases of the sample cohort data. B: 5 variables from
the sample cohort data and the disease codes selection process. C: Extracting the disease-disease relationships and the frequency records
in the Dn x Dm table
Method
Method – Fisher exact test
• Cutoff
• False discovery rate(FDR) p < 0.001
• Relative risk > 4
Result
 Network Construction
775 node
4,100 edge
Edge color - Blue : male-dominant – 329
Red : female-dominant – 1,868
Green: not sex-dominant – 3,539
Results
0-20 20-40
40-60>60
Sex and Age are important factors in determining the structural dynamics of
disease networks.
 Network Construction
Results
 Degree Analysis
• DPN is a typical scale-free network
• The positive correlation between
the in- and out-degrees of diagnoses
Results
• ICD-10 categories are determined according to in- and out-degrees of diagnoses
• Old age has high in- and out-degree
 Degree Analysis
Results
• Community detection in the DPN formed
88 clusters.
• Six giant cluster had distinct properties
(Sex, Aage, ICD-10 categories)
 Community Analysis
Results
• Long-term disease-pair association within 10%
 Duration
Results
 DPN vs. gene-disease network (GDN) of Cancer
 29 disease categories (DPN : 27 pair, GDN : 261 pair)
 14 of 27 links In the DPN overlapped with the links in the GDN
 What is the 13 links?
Example of 13 links Evidence
“Colon cancer” (C18) and
“Prostate cancer” (C61)
Fitzgibbons, R. J. Jr., Lynch, H. T. &
Salerno, G. M. Hereditary colon
cancer syndromes
“Bladder cancer” (C67) and “Lung
cancer” (C34)
Kantor, A. F. & McLaughlin, J. K.
Second cancer following cancer of
the urinary system in Connecticut,
1935–82. Natl Cancer Inst Monogr
68, 149–159 (1985)
Results
 Practical Usability
• Supporting Network visualization according to Sex, Age, Disease-pair, Duration,
Relative Risk and Directionality
Results
Subnetwork
 Usability
Conclusion
 We built a directional weighted network with duration information using
claim data
 We showed that our network had both in-degree and out-degree
distributions following a power law (Scale-free Network)
 Older patients are more likely to have been exposed to various diseases
 Disease Network is grouped by gender, age, and ICD-10 categories.
 Our network presented clinically meaningful connectivity and also identified
connectivity that were not previously found in the gene-disease network
(the macroscopic level, such as the metastasis of cancer)
 The network presented here may potentially serve as a predictive tool for
the diagnosis and treatment of diseases
Paper
대한생물정신의학회
경청해 주셔서 감사합니다.

More Related Content

What's hot

National Cancer Data Ecosystem and Data Sharing
National Cancer Data Ecosystem and Data SharingNational Cancer Data Ecosystem and Data Sharing
National Cancer Data Ecosystem and Data Sharing
Warren Kibbe
 
FDA NGS and Big Data Conference September 2014
FDA NGS and Big Data Conference September 2014FDA NGS and Big Data Conference September 2014
FDA NGS and Big Data Conference September 2014
Warren Kibbe
 
ISCB ECCB BD2K keynote Kibbe 201707
ISCB ECCB BD2K keynote Kibbe 201707ISCB ECCB BD2K keynote Kibbe 201707
ISCB ECCB BD2K keynote Kibbe 201707
Warren Kibbe
 
C-Change Cancer Big Data, NCI Genomic Data Commons, Cloud Pilots
C-Change Cancer Big Data, NCI Genomic Data Commons, Cloud PilotsC-Change Cancer Big Data, NCI Genomic Data Commons, Cloud Pilots
C-Change Cancer Big Data, NCI Genomic Data Commons, Cloud Pilots
Warren Kibbe
 
Human Disease Ontology Project presented at ISB's Biocurator meeting April 2014
Human Disease Ontology Project presented at ISB's Biocurator meeting April 2014Human Disease Ontology Project presented at ISB's Biocurator meeting April 2014
Human Disease Ontology Project presented at ISB's Biocurator meeting April 2014
Lynn Schriml
 
Disease Ontology: mechanistic profiles of human disease
Disease Ontology: mechanistic profiles of human disease Disease Ontology: mechanistic profiles of human disease
Disease Ontology: mechanistic profiles of human disease
Lynn Schriml
 
Disease Ontology: Improvements for Clinical Care and Research Applications
Disease Ontology: Improvements for Clinical Care and Research ApplicationsDisease Ontology: Improvements for Clinical Care and Research Applications
Disease Ontology: Improvements for Clinical Care and Research Applications
Lynn Schriml
 
Cancer summitt 2020 buffalo aug 2011
Cancer summitt 2020 buffalo aug 2011 Cancer summitt 2020 buffalo aug 2011
Cancer summitt 2020 buffalo aug 2011
Camp Days
 
Structuring Genetic Disease Complexity & Environmental Drivers
Structuring Genetic Disease Complexity & Environmental DriversStructuring Genetic Disease Complexity & Environmental Drivers
Structuring Genetic Disease Complexity & Environmental Drivers
Lynn Schriml
 
Elsi of gene therapy, stem cell research copy
Elsi of gene therapy, stem cell research   copyElsi of gene therapy, stem cell research   copy
Elsi of gene therapy, stem cell research copyjayaganesh13
 
OMIM Integration in Human Disease Ontology
OMIM Integration in Human Disease OntologyOMIM Integration in Human Disease Ontology
OMIM Integration in Human Disease Ontology
Lynn Schriml
 
Patient-Organized Genomic Research Studies
Patient-Organized Genomic Research StudiesPatient-Organized Genomic Research Studies
Patient-Organized Genomic Research Studies
Melanie Swan
 
DIYgenomics: An Open Platform for Democratizing the Genome
DIYgenomics: An Open Platform for Democratizing the GenomeDIYgenomics: An Open Platform for Democratizing the Genome
DIYgenomics: An Open Platform for Democratizing the Genome
Melanie Swan
 
Precision Medicine in Oncology Informatics
Precision Medicine in Oncology InformaticsPrecision Medicine in Oncology Informatics
Precision Medicine in Oncology Informatics
Warren Kibbe
 
Mayo presentation 2016
Mayo presentation 2016Mayo presentation 2016
Mayo presentation 2016
Bradford Hesse
 
ciclo autonomico-short paper - Witfor 2016 paper_42
ciclo autonomico-short paper - Witfor 2016 paper_42ciclo autonomico-short paper - Witfor 2016 paper_42
ciclo autonomico-short paper - Witfor 2016 paper_42
.. ..
 
Crowdsourcing applied to knowledge management in translational research: the ...
Crowdsourcing applied to knowledge management in translational research: the ...Crowdsourcing applied to knowledge management in translational research: the ...
Crowdsourcing applied to knowledge management in translational research: the ...
SC CTSI at USC and CHLA
 
PMED: APPM Workshop: Data & Analytics in Precision Oncology- Warren Kibbe, Ma...
PMED: APPM Workshop: Data & Analytics in Precision Oncology- Warren Kibbe, Ma...PMED: APPM Workshop: Data & Analytics in Precision Oncology- Warren Kibbe, Ma...
PMED: APPM Workshop: Data & Analytics in Precision Oncology- Warren Kibbe, Ma...
The Statistical and Applied Mathematical Sciences Institute
 

What's hot (20)

Butterick CV 2016
Butterick CV 2016Butterick CV 2016
Butterick CV 2016
 
National Cancer Data Ecosystem and Data Sharing
National Cancer Data Ecosystem and Data SharingNational Cancer Data Ecosystem and Data Sharing
National Cancer Data Ecosystem and Data Sharing
 
FDA NGS and Big Data Conference September 2014
FDA NGS and Big Data Conference September 2014FDA NGS and Big Data Conference September 2014
FDA NGS and Big Data Conference September 2014
 
ISCB ECCB BD2K keynote Kibbe 201707
ISCB ECCB BD2K keynote Kibbe 201707ISCB ECCB BD2K keynote Kibbe 201707
ISCB ECCB BD2K keynote Kibbe 201707
 
C-Change Cancer Big Data, NCI Genomic Data Commons, Cloud Pilots
C-Change Cancer Big Data, NCI Genomic Data Commons, Cloud PilotsC-Change Cancer Big Data, NCI Genomic Data Commons, Cloud Pilots
C-Change Cancer Big Data, NCI Genomic Data Commons, Cloud Pilots
 
Human Disease Ontology Project presented at ISB's Biocurator meeting April 2014
Human Disease Ontology Project presented at ISB's Biocurator meeting April 2014Human Disease Ontology Project presented at ISB's Biocurator meeting April 2014
Human Disease Ontology Project presented at ISB's Biocurator meeting April 2014
 
Disease Ontology: mechanistic profiles of human disease
Disease Ontology: mechanistic profiles of human disease Disease Ontology: mechanistic profiles of human disease
Disease Ontology: mechanistic profiles of human disease
 
Disease Ontology: Improvements for Clinical Care and Research Applications
Disease Ontology: Improvements for Clinical Care and Research ApplicationsDisease Ontology: Improvements for Clinical Care and Research Applications
Disease Ontology: Improvements for Clinical Care and Research Applications
 
Cancer summitt 2020 buffalo aug 2011
Cancer summitt 2020 buffalo aug 2011 Cancer summitt 2020 buffalo aug 2011
Cancer summitt 2020 buffalo aug 2011
 
Structuring Genetic Disease Complexity & Environmental Drivers
Structuring Genetic Disease Complexity & Environmental DriversStructuring Genetic Disease Complexity & Environmental Drivers
Structuring Genetic Disease Complexity & Environmental Drivers
 
Elsi of gene therapy, stem cell research copy
Elsi of gene therapy, stem cell research   copyElsi of gene therapy, stem cell research   copy
Elsi of gene therapy, stem cell research copy
 
OMIM Integration in Human Disease Ontology
OMIM Integration in Human Disease OntologyOMIM Integration in Human Disease Ontology
OMIM Integration in Human Disease Ontology
 
Patient-Organized Genomic Research Studies
Patient-Organized Genomic Research StudiesPatient-Organized Genomic Research Studies
Patient-Organized Genomic Research Studies
 
DIYgenomics: An Open Platform for Democratizing the Genome
DIYgenomics: An Open Platform for Democratizing the GenomeDIYgenomics: An Open Platform for Democratizing the Genome
DIYgenomics: An Open Platform for Democratizing the Genome
 
Precision Medicine in Oncology Informatics
Precision Medicine in Oncology InformaticsPrecision Medicine in Oncology Informatics
Precision Medicine in Oncology Informatics
 
Mayo presentation 2016
Mayo presentation 2016Mayo presentation 2016
Mayo presentation 2016
 
ciclo autonomico-short paper - Witfor 2016 paper_42
ciclo autonomico-short paper - Witfor 2016 paper_42ciclo autonomico-short paper - Witfor 2016 paper_42
ciclo autonomico-short paper - Witfor 2016 paper_42
 
akulanth604fp_pres
akulanth604fp_presakulanth604fp_pres
akulanth604fp_pres
 
Crowdsourcing applied to knowledge management in translational research: the ...
Crowdsourcing applied to knowledge management in translational research: the ...Crowdsourcing applied to knowledge management in translational research: the ...
Crowdsourcing applied to knowledge management in translational research: the ...
 
PMED: APPM Workshop: Data & Analytics in Precision Oncology- Warren Kibbe, Ma...
PMED: APPM Workshop: Data & Analytics in Precision Oncology- Warren Kibbe, Ma...PMED: APPM Workshop: Data & Analytics in Precision Oncology- Warren Kibbe, Ma...
PMED: APPM Workshop: Data & Analytics in Precision Oncology- Warren Kibbe, Ma...
 

Similar to Network medicine

Final FRD
Final FRDFinal FRD
Final FRD
Nina Shedd
 
Lessons from COVID-19: How Are Data Science and AI Changing Future Biomedical...
Lessons from COVID-19: How Are Data Science and AI Changing Future Biomedical...Lessons from COVID-19: How Are Data Science and AI Changing Future Biomedical...
Lessons from COVID-19: How Are Data Science and AI Changing Future Biomedical...
Jake Chen
 
Genomics, Cellular Networks, Preventive Medicine, and Society
Genomics, Cellular Networks, Preventive Medicine, and SocietyGenomics, Cellular Networks, Preventive Medicine, and Society
Genomics, Cellular Networks, Preventive Medicine, and Society
Larry Smarr
 
Moving from Big Data to Better Models of Disease and Drug Response - Joel Dudley
Moving from Big Data to Better Models of Disease and Drug Response - Joel DudleyMoving from Big Data to Better Models of Disease and Drug Response - Joel Dudley
Moving from Big Data to Better Models of Disease and Drug Response - Joel Dudley
CityAge
 
Federal Research & Development for the Florida system Sept 2014
Federal Research & Development for the Florida system Sept 2014 Federal Research & Development for the Florida system Sept 2014
Federal Research & Development for the Florida system Sept 2014
Warren Kibbe
 
Clinical Genomics and Medicine
Clinical Genomics and MedicineClinical Genomics and Medicine
Clinical Genomics and Medicine
Warren Kibbe
 
ICBO 2014, October 8, 2014
ICBO 2014, October 8, 2014ICBO 2014, October 8, 2014
ICBO 2014, October 8, 2014
Warren Kibbe
 
Twenty Years of Whole Slide Imaging - the Coming Phase Change
Twenty Years of Whole Slide Imaging - the Coming Phase ChangeTwenty Years of Whole Slide Imaging - the Coming Phase Change
Twenty Years of Whole Slide Imaging - the Coming Phase Change
Joel Saltz
 
Amia tb-review-15
Amia tb-review-15Amia tb-review-15
Amia tb-review-15
Russ Altman
 
Human Disease and Genomics
Human Disease and GenomicsHuman Disease and Genomics
Human Disease and Genomics
oliai
 
Twenty Years of Whole Slide Imaging - the Coming Phase Change
Twenty Years of Whole Slide Imaging - the Coming Phase ChangeTwenty Years of Whole Slide Imaging - the Coming Phase Change
Twenty Years of Whole Slide Imaging - the Coming Phase Change
Joel Saltz
 
AI and whole slide imaging biomarkers
AI and whole slide imaging biomarkersAI and whole slide imaging biomarkers
AI and whole slide imaging biomarkers
Joel Saltz
 
Morphologomics - Challenges for Surgical Pathology in the Genomic Age by Dr. ...
Morphologomics - Challenges for Surgical Pathology in the Genomic Age by Dr. ...Morphologomics - Challenges for Surgical Pathology in the Genomic Age by Dr. ...
Morphologomics - Challenges for Surgical Pathology in the Genomic Age by Dr. ...
Cirdan
 
Genomics in Society: Genomics, Cellular Networks, Preventive Medicine, and So...
Genomics in Society: Genomics, Cellular Networks, Preventive Medicine, and So...Genomics in Society: Genomics, Cellular Networks, Preventive Medicine, and So...
Genomics in Society: Genomics, Cellular Networks, Preventive Medicine, and So...
Larry Smarr
 
Khoury ashg2014
Khoury ashg2014Khoury ashg2014
Khoury ashg2014muink
 
Quantitative Medicine Feb 2009
Quantitative Medicine Feb 2009Quantitative Medicine Feb 2009
Quantitative Medicine Feb 2009Ian Foster
 
TCGC The Clinical Genome Conference 2015
TCGC The Clinical Genome Conference 2015TCGC The Clinical Genome Conference 2015
TCGC The Clinical Genome Conference 2015
Nicole Proulx
 
Digital Pathology, FDA Approval and Precision Medicine
Digital Pathology, FDA Approval and Precision MedicineDigital Pathology, FDA Approval and Precision Medicine
Digital Pathology, FDA Approval and Precision Medicine
Joel Saltz
 
Advancing Innovation and Convergence in Cancer Research: US Federal Cancer Mo...
Advancing Innovation and Convergence in Cancer Research: US Federal Cancer Mo...Advancing Innovation and Convergence in Cancer Research: US Federal Cancer Mo...
Advancing Innovation and Convergence in Cancer Research: US Federal Cancer Mo...
Jerry Lee
 
Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...
Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...
Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...
Philip Bourne
 

Similar to Network medicine (20)

Final FRD
Final FRDFinal FRD
Final FRD
 
Lessons from COVID-19: How Are Data Science and AI Changing Future Biomedical...
Lessons from COVID-19: How Are Data Science and AI Changing Future Biomedical...Lessons from COVID-19: How Are Data Science and AI Changing Future Biomedical...
Lessons from COVID-19: How Are Data Science and AI Changing Future Biomedical...
 
Genomics, Cellular Networks, Preventive Medicine, and Society
Genomics, Cellular Networks, Preventive Medicine, and SocietyGenomics, Cellular Networks, Preventive Medicine, and Society
Genomics, Cellular Networks, Preventive Medicine, and Society
 
Moving from Big Data to Better Models of Disease and Drug Response - Joel Dudley
Moving from Big Data to Better Models of Disease and Drug Response - Joel DudleyMoving from Big Data to Better Models of Disease and Drug Response - Joel Dudley
Moving from Big Data to Better Models of Disease and Drug Response - Joel Dudley
 
Federal Research & Development for the Florida system Sept 2014
Federal Research & Development for the Florida system Sept 2014 Federal Research & Development for the Florida system Sept 2014
Federal Research & Development for the Florida system Sept 2014
 
Clinical Genomics and Medicine
Clinical Genomics and MedicineClinical Genomics and Medicine
Clinical Genomics and Medicine
 
ICBO 2014, October 8, 2014
ICBO 2014, October 8, 2014ICBO 2014, October 8, 2014
ICBO 2014, October 8, 2014
 
Twenty Years of Whole Slide Imaging - the Coming Phase Change
Twenty Years of Whole Slide Imaging - the Coming Phase ChangeTwenty Years of Whole Slide Imaging - the Coming Phase Change
Twenty Years of Whole Slide Imaging - the Coming Phase Change
 
Amia tb-review-15
Amia tb-review-15Amia tb-review-15
Amia tb-review-15
 
Human Disease and Genomics
Human Disease and GenomicsHuman Disease and Genomics
Human Disease and Genomics
 
Twenty Years of Whole Slide Imaging - the Coming Phase Change
Twenty Years of Whole Slide Imaging - the Coming Phase ChangeTwenty Years of Whole Slide Imaging - the Coming Phase Change
Twenty Years of Whole Slide Imaging - the Coming Phase Change
 
AI and whole slide imaging biomarkers
AI and whole slide imaging biomarkersAI and whole slide imaging biomarkers
AI and whole slide imaging biomarkers
 
Morphologomics - Challenges for Surgical Pathology in the Genomic Age by Dr. ...
Morphologomics - Challenges for Surgical Pathology in the Genomic Age by Dr. ...Morphologomics - Challenges for Surgical Pathology in the Genomic Age by Dr. ...
Morphologomics - Challenges for Surgical Pathology in the Genomic Age by Dr. ...
 
Genomics in Society: Genomics, Cellular Networks, Preventive Medicine, and So...
Genomics in Society: Genomics, Cellular Networks, Preventive Medicine, and So...Genomics in Society: Genomics, Cellular Networks, Preventive Medicine, and So...
Genomics in Society: Genomics, Cellular Networks, Preventive Medicine, and So...
 
Khoury ashg2014
Khoury ashg2014Khoury ashg2014
Khoury ashg2014
 
Quantitative Medicine Feb 2009
Quantitative Medicine Feb 2009Quantitative Medicine Feb 2009
Quantitative Medicine Feb 2009
 
TCGC The Clinical Genome Conference 2015
TCGC The Clinical Genome Conference 2015TCGC The Clinical Genome Conference 2015
TCGC The Clinical Genome Conference 2015
 
Digital Pathology, FDA Approval and Precision Medicine
Digital Pathology, FDA Approval and Precision MedicineDigital Pathology, FDA Approval and Precision Medicine
Digital Pathology, FDA Approval and Precision Medicine
 
Advancing Innovation and Convergence in Cancer Research: US Federal Cancer Mo...
Advancing Innovation and Convergence in Cancer Research: US Federal Cancer Mo...Advancing Innovation and Convergence in Cancer Research: US Federal Cancer Mo...
Advancing Innovation and Convergence in Cancer Research: US Federal Cancer Mo...
 
Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...
Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...
Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...
 

Recently uploaded

How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
SwisschemDerma
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
NEHA GUPTA
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
Thangamjayarani
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Yodley Lifesciences
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
SwastikAyurveda
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
Suraj Goswami
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 

Recently uploaded (20)

How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 

Network medicine

  • 1. 대한생물정신의학회 2018 춘계 학술대회 Construction and Interpretation of Disease Network using Clinical Data 차의과학대학교 의학전문대학원 정보의학교실 한현욱 (M.D, Ph.D) stepano7@gmail.com
  • 2. C.V  Position  Head Professor, Dept. of Biomedical Informatics, CHA University  Head, Healthcare Big Data Laboratory, CHA University (CHABI)  Scientific Program Committee Member, Translational Bioinformatics Conference  Instructor, GDA and CPBMI, KOSMI  Advisor Medibloc, Syntecabio, and MISOinfo  Education  CPBMI, Certified Physician in BioMedical Informatics, KOSMI  Ph.D, Biomedical Informatics, Graduate School of Medicine, CHA University  M.D, Gradate School of Medicine, CHA University  M.S, Dept. of Electrical & Computer Engineering, Seoul National University  B.S, Dept. of Electrical & Computer Engineering, Hanyang University  Work  Research Assistant Professor, Dept. of Biomedical Informatics, Ajou University  Clinical Assistant Professor, Dept. of Preventive Medicine, CHA University  Research Scientist, Systems Biomedical Informatics Research Center, SNU  R&D Engineer, LG Electronics R&D Campus
  • 7. Biological Network Protein Interaction Network Network biology Network Medicine Regulatory Network Metabolic Network Cell Signaling Network Perturbation Sensitivity Network Social Network Disease Network Drug Target Network
  • 8. Network Science  20C Network (Complex System) Science  Opposing to Reductionism  Barabasi et al.  Network Topologies Random Network Scale-free Network
  • 9. Characterization of Real Network P(k) ∝ λ-γ (2 < γ < 3) Hub node vs. peripheral node Evolution Small world phenomenon Six degrees of separation The 80/20 rule Rich get richer Achilles' Heel  Scale-free network  Network growth  Preferential attachment Social Network Internet Network Biological Network log-log
  • 10. Previous Researches of Biological Network PPI is scale-free (Barabasi, 2000) Centrality & Lethality rule (Jeong, 2001) Hubs evolve slowly (Fraser, 2002) Disease : clustering, tissue specificity & Periphery (Goh, 2007) Drug target : similar with disease genes (Yildirim, 2007)
  • 12. Data source for Construction of Disease Network Disease A – Gene 1 Disease B – Gene 1  Disease A – Gene 1 -- Disease B  Disease A- Disease B
  • 13. Previous Disease Network  Human Genes – Disease network (Koh et al. 2007, PNAS) : Gene Base
  • 14. Previous Disease Network  Human Symptoms – Disease Network (Barabasi et al. 2014, Nature Communication) : EMR Base Disease A – Symptom 1 Disease B – Symptom 1  Disease A – Symptom 1 -- Disease B  Disease A- Disease B
  • 15. Previous Disease Network  Disease Comorbidity Network (Yang Chen, 2015, AMIA) 상병명 : Disease A ,Disease B  Disease A- Disease B
  • 16. Motivation  Definition of Disease (Wiki)  질병(疾病)이란 유기체의 신체적 기능이 비정상적으로 된 상태를 일컫는다.  인간에게 있어서 질병이란 넓은 의미에서는 극도의 고통을 비롯해 스트레스, 사회적인 문제, 신체기관의 기능 장애와 죽음에까지를 포괄한다.  질병이란 개인만에 한정되는 것이 아니어서 사회적으로 큰 맥락에서 이해되기도 한다.  더 넓게는 사고나 장애, 증후군, 감염, 행동 장애 등을 모두 나타낼 수 있다.  질병의 종류에는 약 30000가지 정도가 있다고 한다.
  • 17. Motivation  Genetic Disease Vs. Non-Genetic Disease  Many diseases have no genetic basis at all. Usually a physical injury such as a bone fracture is not caused by genetics when it is caused by something else. (Of course, there could still be an underlying genetic cause of weak bones or osteoporosis that really caused the fracture.) Similarly, a virus or bacterial infection is caused by an external microbe  예방의학교과서  유전체로 설명될 수 있는 질환은 20~30% 정도로 알려져 있음 Most diseases are non-genetic
  • 18. Motivation The Same Symptom – Different Disease DDx is very important!!
  • 19. Motivation  Sex Sex is one of the clinical factors of disease
  • 20. Motivation  Age Age is a important clinical factor of disease
  • 21. Motivation History - Disease - Drug - Family - Socio-economy - Operation - Mensturation (F) A disease is risk factor of another disease
  • 22. Motivation  Causality and Risk Clinically, Disease Network is Directed and Weighted D1 D2 D4 D5 D3 D1 D2 D4 D5 D3 60 10 20 12 7 32 Non-directed and non- weighted Directed and Weighted
  • 23. Motivation  Network Visualization A clinician likes incidence-based node Presentation D1 D2 D4 D5 D3 D1 D2 D4 D5 D3 60 10 20 12 7 32 Centrality-based Node Presentation Incidence-based Node Presentation
  • 24. Motivation  Navigation of Disease Network Help for a Clinician and a Cheat Sheet for Research
  • 25. Problem of Clinical Data Data Fragmentation
  • 27. NHIS Cohort Data A B C A B, BC, AC Sex, Age, Direction, Weight, Duration
  • 28. Method • Assumption • we extracted all combinations of disease-disease pairs from each patient’s transition based on the assumption that “previous incidence would become a cause (or act as a risk factor) of later incidence” . • Step 1. 3 types of event sequence: • Incidence sequence • Ex: A  B  C  D • Step 2. Extracting disease-disease pairs: • Disease-disease pairs : (A  B), (A  C), (A  D), (B  C), (B  D), (C  D) • Step 3. Record the frequency of each disease- disease pair
  • 29. Method Statistical analysis and constructions of the human disease directed network. A: databases of the sample cohort data. B: 5 variables from the sample cohort data and the disease codes selection process. C: Extracting the disease-disease relationships and the frequency records in the Dn x Dm table
  • 30. Method Method – Fisher exact test • Cutoff • False discovery rate(FDR) p < 0.001 • Relative risk > 4
  • 31. Result  Network Construction 775 node 4,100 edge Edge color - Blue : male-dominant – 329 Red : female-dominant – 1,868 Green: not sex-dominant – 3,539
  • 32. Results 0-20 20-40 40-60>60 Sex and Age are important factors in determining the structural dynamics of disease networks.  Network Construction
  • 33. Results  Degree Analysis • DPN is a typical scale-free network • The positive correlation between the in- and out-degrees of diagnoses
  • 34. Results • ICD-10 categories are determined according to in- and out-degrees of diagnoses • Old age has high in- and out-degree  Degree Analysis
  • 35. Results • Community detection in the DPN formed 88 clusters. • Six giant cluster had distinct properties (Sex, Aage, ICD-10 categories)  Community Analysis
  • 36. Results • Long-term disease-pair association within 10%  Duration
  • 37. Results  DPN vs. gene-disease network (GDN) of Cancer  29 disease categories (DPN : 27 pair, GDN : 261 pair)  14 of 27 links In the DPN overlapped with the links in the GDN  What is the 13 links? Example of 13 links Evidence “Colon cancer” (C18) and “Prostate cancer” (C61) Fitzgibbons, R. J. Jr., Lynch, H. T. & Salerno, G. M. Hereditary colon cancer syndromes “Bladder cancer” (C67) and “Lung cancer” (C34) Kantor, A. F. & McLaughlin, J. K. Second cancer following cancer of the urinary system in Connecticut, 1935–82. Natl Cancer Inst Monogr 68, 149–159 (1985)
  • 38. Results  Practical Usability • Supporting Network visualization according to Sex, Age, Disease-pair, Duration, Relative Risk and Directionality
  • 40. Conclusion  We built a directional weighted network with duration information using claim data  We showed that our network had both in-degree and out-degree distributions following a power law (Scale-free Network)  Older patients are more likely to have been exposed to various diseases  Disease Network is grouped by gender, age, and ICD-10 categories.  Our network presented clinically meaningful connectivity and also identified connectivity that were not previously found in the gene-disease network (the macroscopic level, such as the metastasis of cancer)  The network presented here may potentially serve as a predictive tool for the diagnosis and treatment of diseases
  • 41. Paper

Editor's Notes

  1. 즉 4차 산업혁명은 데이터 혁명이라고 해도 결코 지나치지 않습니다.
  2. 이를 위해 먼저 헬스케어 데이터에는 어떤것이 있는지 간단히 살펴보고 이슈가 되는 몇가지 사항에 대하 정리할 필요가 있습니다.
  3. 또 하나 중요한 헬스케어 데이터가 바로 연구데이터 입니다 . 최근 대학 병원에서는 임상시험 센터를 유행처럼 만들고 있습니다. 이를 통해, 병원의 수익을 올릴 뿐만 아니라, 신약 혹은 새로운 치료법에 관한 임상적 관찰된 데이터가 쏟아지고 있어… 최근에는 이런 데이터를 전문적으로 관리 및 분석하기 위한 IT인프라가 구축되고 있습니다. 대표적인 예가 세브란스의 e-CASE라는 서비스인데, 이런 서비스를 활용해 기존의 병원정보시스템의 데이터와 임상시험 데이터를 연계한 빅데이터 분석이 이루어 지고 있습니다. 분자생물학의 발전으로 인해 현재, 웻 랩에서 생상되는 다양한 분자생물학 실험 데이터가 생산되고 있습니다. 최근에는 하이스루풋 분자생물학 실험 데이터가 쏟아지고 있어 연구실 차원의 분자생물학 데이터가 넘쳐나고 있고 이를 관리하기 위한 다양한 림스가 등장하고 있습니다. 한편, 전세계적으로 다양한 생물학적 데이터베이스가 무료로 개방되고 있는데 이를 분석하기 위한 DAVI와 같은 생명정보분석 시스템도 계속해서 등장하고 있는중 입니다.
  4. 웨어러블과 스마트기기의 발전으로 인해 과거에는 존재하지 않았던 헬스케어 데이터가 이제는 의료기관 밖에서도 생산되고 있습니다. 여기서 문제점은 디지털 헬스케어 업체마다 데이터 형태가 너무 다양해 표준화 시키기 어렵다는게 문제입니다. 최근에는 모바일 헬스케어 표준안에 관한 다양한 연구가 본격적으로 진행중에 있어 미래에는 데이터 개방으로 인해 다양한 PGHD가 생산되고 활용될것으로 기대됩니다. 현재, 이런 데이터를 활용해 독감예측 을 위한 모바일닥터, 벨트형 비만관리앱 웰트, 당뇨관리 앱 휴레이 포지티브와 같은 디지털 헬스케어 기업이 만들어지고 있습니다.
  5. 매우 혼란스러울 겁니다. 왜냐하면 일본과 한국의 표준화 방법이 다르기 때문입니다. 따라서 하루 빨리 표준화를 이루기 위해 노력해야 합니다.
  6. 데이터에 대한 신뢰성, 무결성, 보안성 그리고 투명성을 확보해야 합니다. 그리고 데이터 제공자에게 적절한 보상이 이루어져야 하며 데이터에 대한 표준화 이슈도 함께 해결해야 합니다.
  7. 경청해주셔서 감사합니다.